EXE844 clinical trials
How each study uses EXE844 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- EXE844 Sterile Otic Suspension, 0.3%
- 3
Who runs them
Industry 3 · Other 0
Studies
Open first, then newest update. How each study uses EXE844 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Pediatric Pharmacokinetic (PK) Study of EXE844 Otic Suspension in Otitis Media at the Time of Tympanostomy Tube Insertion (OMTT)CompletedPhase 1Alcon ResearchNCT02539654Written as EXE844 Sterile Otic Suspension, 0.3%
- Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT) - Study 2CompletedPhase 3Alcon ResearchNCT02436304Written as EXE844 Sterile Otic Suspension, 0.3%
- Safety and Efficacy of EXE844 Otic Suspension in Otitis Media at Time of Tympanostomy Tube Insertion (OMTT)CompletedPhase 3Alcon ResearchNCT02432105Written as EXE844 Sterile Otic Suspension, 0.3%